Becton Dickinson
Becton Dickinson
Becton Dickinson (BD) is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. BD’s 40,000 associates in 50 countries work with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
Collaboration and a mindset of continuous improvement are at the core of BD operations. BD applies lean and continuous improvement methodologies across the enterprise to drive efficiency and cost effectiveness.
As a Better Buildings Better Plants Challenge Partner, BD has committed to a 25% energy reduction (per unit of production or square footage) and a 20% water reduction by 2024 from its 2014 baseline.

NAICS 339, Miscellaneous Manufacturing
Energy Goals |
---|
25%Reduction in Energy Intensity 25% Reduction in Energy Intensity by 2024 across 36 manufacturing, distribution, and R&D sites in the US
![]() | Progress |
Water Goals |
20%Reduction in Water Intensity 25% Reduction in Water Intensity by 2024 across 36 manufacturing, distribution, and R&D sites in the US
![]() | Progress |